Colesevelam, Ezetimibe, and Patients With Type 2 Diabetes Mellitus
Lists
Only you see this
Abstract
In this health care database analysis among patients with HCh and T2DM, colesevelam was associated with decreased risk of a composite CV event compared with ezetimibe, despite lower persistence.
BibTeX
@article{swindle2014colesevelam,
author = {Jason Swindle and Xin Ye and Rajiv Mallick and Rui Song and Thomas Horstman and Harold Bays},
title = {{Colesevelam, Ezetimibe, and Patients With Type 2 Diabetes Mellitus}},
journal = {Annals},
year = {2014},
doi = {10.1177/1060028014531737},
}Loading related content...